Company / Total Assets
TEVA PHARMACEUTICAL INDUSTRIES LTD Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$40.7B
FY2025
5-year range
$39.3B / $47.7B
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
#10 of 214
Health Care
What the data says
Among 214 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the top 5% for total assets. Total Assets returned to growth in FY2025 after 8 years of decline, reaching $40.7B.
Based on SEC 10-K filings.
$40.7B in FY2025 with a 5-year CAGR of -4.3%. Top quartile in the Health Care sector.
Declined from $43.5B to $40.7B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -3.9%
- 5-Year CAGR
- -4.3%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 214This company $40.7B Sector average $7.5B
▼
+445.5% above sector average
Key checks
Key Insights
- 5-year CAGR of -4.3%, indicating a declining trend.
- In FY2025, total assets increased 3.6% year-over-year.
- Ranks #10 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $40.7B | +3.6% |
| FY2024 | $39.3B | -9.6% |
| FY2023 | $43.5B | -5.3% |
| FY2022 | $45.9B | -3.6% |
| FY2021 | $47.7B | -5.9% |
| FY2020 | $50.6B | -11.9% |
| FY2019 | $57.5B | -5.3% |
| FY2018 | $60.7B | -14.1% |
| FY2017 | $70.6B | -24.1% |
| FY2016 | $93.1B | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026